MoneyWorks4Me

Biocon informs about press release

13 May 2024 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda® (Liraglutide) in Mexico with Medix.’ The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1790.10
Dr. Reddys Labs. 1201.20
Cipla 1326.60
Lupin 2008.50
Zydus Lifesciences 1140.70
View more..